Jade Therapeutics, Inc. — Form D
Jade Therapeutics, Inc. of SALT LAKE CITY, X1, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-31. The offering totals $800K. Industry: Biotechnology.
Offering
- Filed: 2014-12-31
- Form: D
- Accession: 0001591214-14-000002
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $800K
- Remaining: $800K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-231146
Issuer
- Name: Jade Therapeutics, Inc.
- CIK: 0001591214
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 675 ARAPEEN DR., SUITE 302, SALT LAKE CITY, X1, 84108-1228
- Phone: 646-918-7479
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Arthur Klausner | Director | Bedford, NY |
| Randall Olson | Director | Salt Lake City, UT |
| DINESH PATEL | Director | Bothell, WA |
| Mary Jane Rafii | Director | Wilton, CT |
| Barbara Wirostko | Director | Dedham, MA |
| Arthur Klausner | Executive Officer | Bedford, NY |
| Mary Jane Rafii | Executive Officer | Wilton, CT |
| Barbara Wirostko | Executive Officer | Dedham, MA |
Other filings by this issuer (1)
More